CRXL Had an upgap today as it went over its May 10 H of 20.44 Volume remains moderate at 136Ks
bigcharts.marketwatch.com
It announced today that it has discovered an antibody against the WNV. which seems to be working in animal trials.<g>
Bernard
AMSTERDAM, June 10 (Reuters) - Dutch biotechnology firm Crucell (CRCL.AS: Quote, Profile, Research) (CRXL.O: Quote, Profile, Research) said on Friday it had discovered a human antibody for protection against West Nile virus that has proven effective in animal studies.
"Study results have demonstrated that the fully human monoclonal antibody, derived from patients who survived West Nile infection, effectively neutralized the virus in cell culture and fully protected mice from an otherwise lethal infection," Crucell said in a statement.
Crucell shares gained on the news, rising 4.4 percent to 17 euros, their highest level since October 2000, the month of their initial public offering.
The company, which has never reported a profit, has reported significant progress in developing vaccines against Ebola, the West Nile Virus and SARS.
Crucell's West Nile virus vaccine development programme is due to enter clinical trials at the end of this year.
Since appearing in New York in 1999, the West Nile virus has spread by mosquitos throughout the United States. In 2004, there were 2,470 recorded cases of the disease and 88 fatalities caused by a form of encephalitis, or inflammation of the brain. |
